Related articles

• Article

  A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.

  Int. J. Radiat. Oncol. Biol. Phys. 2017 Mar 1; 97 (3): 487-494.

• Article

  IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry.

  Oncotarget. 2015 Dec 1; 6 (38): 40896-906.

• Article

  Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study.

  Neurol. Med. Chir. (Tokyo). 2014 Jan 1; 54 (4): 272-9.

Show more related articles...